UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Genomic scars as biomarkers of homologous recombination deficiency and drug response in breast and ovarian cancers

Breast cancer research : BCR, 2014-06, Vol.16 (3), p.211-211, Article 211

2014

Volltextzugriff (PDF)

Targeting folate receptor alpha for cancer treatment

Oncotarget, 2016-08, Vol.7 (32), p.52553-52574

2016

Volltextzugriff (PDF)

Random Forest Modelling of High-Dimensional Mixed-Type Data for Breast Cancer Classification

Cancers, 2021-02, Vol.13 (5), p.991

2021

Volltextzugriff (PDF)

Pan-cancer transcriptomic analysis dissects immune and proliferative functions of APOBEC3 cytidine deaminases

Nucleic acids research, 2019-02, Vol.47 (3), p.1178-1194

2019

Volltextzugriff (PDF)

FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer

Cancer research (Chicago, Ill.), 2010-03, Vol.70 (5), p.2085-2094

2010

Volltextzugriff (PDF)

Inducible localized delivery of an anti-PD-1 scFv enhances anti-tumor activity of ROR1 CAR-T cells in TNBC

Breast cancer research : BCR, 2022-06, Vol.24 (1), p.39-39, Article 39

2022

Volltextzugriff (PDF)

Transcriptome analysis of mammary epithelial subpopulations identifies novel determinants of lineage commitment and cell fate

BMC genomics, 2008-12, Vol.9 (1), p.591-591, Article 591

2008

Volltextzugriff (PDF)

PAK6 acts downstream of IQGAP3 to promote contractility in triple negative breast cancer cells

Cellular signalling, 2024-09, Vol.121, p.111233, Article 111233

2024

Volltextzugriff (PDF)

A Distinct Spectrum of Copy Number Aberrations in Pediatric High-Grade Gliomas

Clinical cancer research, 2010-07, Vol.16 (13), p.3368-3377

2010

Volltextzugriff (PDF)

Dual Mechanisms of LYN Kinase Dysregulation Drive Aggressive Behavior in Breast Cancer Cells

Cell reports (Cambridge), 2018-12, Vol.25 (13), p.3674-3692.e10

2018

Volltextzugriff (PDF)

Selectin Ligand Sialyl-Lewis x Antigen Drives Metastasis of Hormone-Dependent Breast Cancers

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24), p.7683-7693

2011

Volltextzugriff (PDF)

Comparison of basal-like triple-negative breast cancer defined by morphology, immunohistochemistry and transcriptional profiles

Modern pathology, 2013-07, Vol.26 (7), p.955-966

2013

Volltextzugriff (PDF)

Evaluation of CDK12 Protein Expression as a Potential Novel Biomarker for DNA Damage Response-Targeted Therapies in Breast Cancer

Molecular cancer therapeutics, 2018-01, Vol.17 (1), p.306-315

2018

Volltextzugriff (PDF)

Integrated genomics and functional validation identifies malignant cell specific dependencies in triple negative breast cancer

Nature communications, 2018-03, Vol.9 (1), p.1044-16, Article 1044

2018

Volltextzugriff (PDF)

B Cells in Breast Cancer Pathology

Cancers, 2023-02, Vol.15 (5), p.1517

2023

Volltextzugriff (PDF)

Integrin-Mediated Macrophage Adhesion Promotes Lymphovascular Dissemination in Breast Cancer

Cell reports (Cambridge), 2019-05, Vol.27 (7), p.1967-1978.e4

2019

Volltextzugriff (PDF)

B cell profiles, antibody repertoire and reactivity reveal dysregulated responses with autoimmune features in melanoma

Nature communications, 2023-06, Vol.14 (1), p.3378-3378, Article 3378

2023

Volltextzugriff (PDF)

Immune Crosstalk Between Lymph Nodes and Breast Carcinomas, With a Focus on B Cells

Frontiers in molecular biosciences, 2021-05, Vol.8, p.673051-673051

2021

Volltextzugriff (PDF)

Molecular patterns of cancer colonisation in lymph nodes of breast cancer patients

Breast cancer research : BCR, 2018-11, Vol.20 (1), p.143-143, Article 143

2018

Volltextzugriff (PDF)

Microarray-Based Class Discovery for Molecular Classification of Breast Cancer: Analysis of Interobserver Agreement

JNCI : Journal of the National Cancer Institute, 2011-04, Vol.103 (8), p.662-673

2011

Volltextzugriff (PDF)

Invasive breast cancer over four decades reveals persisting poor metastatic outcomes in treatment resistant subgroup – the “ATRESS” phenomenon

Breast (Edinburgh), 2020-04, Vol.50, p.39-48

2020

Volltextzugriff (PDF)

Immunological visibility: posttranscriptional regulation of human NKG2D ligands by the EGF receptor pathway

Science translational medicine, 2014-04, Vol.6 (231), p.231ra49

2014

Volltextzugriff (PDF)

IL15RA Drives Antagonistic Mechanisms of Cancer Development and Immune Control in Lymphocyte-Enriched Triple-Negative Breast Cancers

Cancer research (Chicago, Ill.), 2014-09, Vol.74 (17), p.4908-4921

2014

Volltextzugriff (PDF)

An RNAi screen of Rho signalling networks identifies RhoH as a regulator of Rac1 in prostate cancer cell migration

BMC biology, 2018-03, Vol.16 (1), p.29-29, Article 29

2018

Volltextzugriff (PDF)

1 – 25 von 142

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(136)
Mit Volltextzugriff
(126)

Publikationsform

Artikel
(141)
Buchkapitel
(1)

Sprache

Englisch
(142)
Japanisch
(26)

Erscheinungsjahr

n.n

Thema

Science & Technology
(94)
Life Sciences & Biomedicine
(84)
Humans
(76)
Oncology
(62)
Breast Cancer
(54)
Female
(50)
Tumors
(46)
Gene Expression
(30)
Breast Neoplasms - Genetics
(29)
Gene Expression Profiling
(26)
Breast Neoplasms - Pathology
(24)
Cancer
(23)
Cell Line, Tumor
(22)
Animals
(20)
Mice
(18)
Biological And Medical Sciences
(17)
Biomarkers
(17)
Gene Expression Regulation, Neoplastic
(17)
Medical Sciences
(17)
Genes
(16)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial

Genomic scars as biomarkers of homologous recombination deficiency and drug response in breast and ovarian cancers

Targeting folate receptor alpha for cancer treatment

Random Forest Modelling of High-Dimensional Mixed-Type Data for Breast Cancer Classification

Pan-cancer transcriptomic analysis dissects immune and proliferative functions of APOBEC3 cytidine deaminases

FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer

Inducible localized delivery of an anti-PD-1 scFv enhances anti-tumor activity of ROR1 CAR-T cells in TNBC

Transcriptome analysis of mammary epithelial subpopulations identifies novel determinants of lineage commitment and cell fate

PAK6 acts downstream of IQGAP3 to promote contractility in triple negative breast cancer cells

A Distinct Spectrum of Copy Number Aberrations in Pediatric High-Grade Gliomas

Dual Mechanisms of LYN Kinase Dysregulation Drive Aggressive Behavior in Breast Cancer Cells

Selectin Ligand Sialyl-Lewis x Antigen Drives Metastasis of Hormone-Dependent Breast Cancers

Comparison of basal-like triple-negative breast cancer defined by morphology, immunohistochemistry and transcriptional profiles

Evaluation of CDK12 Protein Expression as a Potential Novel Biomarker for DNA Damage Response-Targeted Therapies in Breast Cancer

Integrated genomics and functional validation identifies malignant cell specific dependencies in triple negative breast cancer

B Cells in Breast Cancer Pathology

Integrin-Mediated Macrophage Adhesion Promotes Lymphovascular Dissemination in Breast Cancer

B cell profiles, antibody repertoire and reactivity reveal dysregulated responses with autoimmune features in melanoma

Immune Crosstalk Between Lymph Nodes and Breast Carcinomas, With a Focus on B Cells

Molecular patterns of cancer colonisation in lymph nodes of breast cancer patients

Microarray-Based Class Discovery for Molecular Classification of Breast Cancer: Analysis of Interobserver Agreement

Invasive breast cancer over four decades reveals persisting poor metastatic outcomes in treatment resistant subgroup – the “ATRESS” phenomenon

Immunological visibility: posttranscriptional regulation of human NKG2D ligands by the EGF receptor pathway

IL15RA Drives Antagonistic Mechanisms of Cancer Development and Immune Control in Lymphocyte-Enriched Triple-Negative Breast Cancers

An RNAi screen of Rho signalling networks identifies RhoH as a regulator of Rac1 in prostate cancer cell migration

Suchergebnisse filtern